You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
1Monash University, Melbourne, Australia. gillian.duchesne@med.monash.edu.au
Technological advances in radiotherapy for prostate cancer enable dose escalation, reducing normal tissue damage and potentially improving tumor control. Evidence suggests this approach offers survival rates comparable to surgery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: